Showing posts with label total chol - LDL ratio. Show all posts
Showing posts with label total chol - LDL ratio. Show all posts

Tuesday, 9 April 2013

Dr. Thomas Dayspring | Cholesterol Testing: What Matters Most? - ATLCX (Episode 29):

ATLCX (Episode 29): Dr. Thomas Dayspring | Cholesterol Testing: What Matters Most? « Jimmy Moore's Livin' La Vida Low Carb Blog

In Episode 29 of “Jimmy Moore Presents: Ask The Low-Carb Experts,” we’re very excited to bring to you one of the world’s leading lipidologists and experts on just about everything you could ever want to know about cholesterol numbers named Dr. Thomas Dayspring from LecturePad.org.

He’s the Director of Cardiovascular Education at the Foundation for Health Improvement and Technology in Richmond, Virginia and is one of the most requested speakers in the United States with expertise on atherothrombosis, lipoprotein and vascular biology, advanced lipoprotein testing and more. Dr. Dayspring has given over 4000 lectures in all 50 states educating medical professionals and the lay public alike.

Many of you first heard Dr. Dayspring in Episode 585 of “The Livin’ La Vida Low-Carb Show” podcast and afterwards my listeners had lots of questions for Dr. Dayspring about cholesterol. That’s why we decided to bring him back on ATLCX to take on the topic “Cholesterol Testing: What Matters Most?” so you can speak directly with him about your burning questions on your cholesterol concerns.

This was a golden opportunity to get better clarification on any issues regarding cholesterol testing that concern you. Listen in to hear what Dr. Thomas Dayspring had to say as he took on your questions about the most important factors in cholesterol testing in EPISODE 29 on October 4, 2012.

Listen to Dr. Thomas Dayspring on “Cholesterol Testing: What Matters Most?”:
  • People are concerned (and confused) about cholesterol
  • Gary Taubes/Peter Attia turned him on to community
  • Atheroschlerosis “build-up of cholesterol” in arterial wall
  • Blood tests help doctors determine heart disease risk
  • People with heart disease have cholesterol levels “all over the place”
  • Even persons with seemingly “perfect cholesterol” can get atheroschlerosis
  • Tim Russert is a perfect example of this
  • No human has any cholesterol floating around in blood as a free molecule
  • Lipids must bind to protein to become soluble in water (plasma)
  • Lipids bound to apoproteins are lipoproteins which traffic lipids in plasma
  • This “illegal dump job” (lipoproteins carrying cholesterol into the artery) can lead to atherosclerosis
  • Thus atherogenesis is a lipoprotein-mediated disease
  • Atherogenic lipoproteins (lipoproteins that enter the artery wall) are the “bad guys”
  • The goal is to avoid lipoproteins from penetrating the artery wall
  • We have to have labs that measure lipoprotein concentrations, rather than lipid concentrations
  • This (particle concentrations) is the type of testing we all need to have done
  • Omega-3 and omega-6 fatty acids are within the phospholipids delivered by lipoproteins
  • The types of lipoproteins: VLDL, IDL, LDL and HDL
  • Traditional tests look at cholesterol measurements like the total cholesterol (TC)
  • TC is the amount of cholesterol carried within all of the lipoproteins per deciliter of plasma
  • HDL-cholesterol has as its surface apoprotein, apolipoprotein A-1
  • ApoA-I measurement serves as an HDL particle count
  • You can have a lot of HDL particles, but low HDL-cholesterol
  • Thus although apoA-I and HDL-C usually correlate, in some folks they do not (discordance)
  • People with low HDL-C but normal apoA-I tend not to get heart disease
  • Those with high HDL-cholesterol could have low Apo A-1 (low HDL particle count)
  • There is one apoB molecule per VLDL, IDL and LDL particle: apoB is not on HDL particles
  • Apo B testing measures how many VLDL, IDL and LDL exists per deciliter of plasma
  • Apo A-1 particle do not deposit cholesterol in the artery: they may in fact remove it.
  • Apo B particles after entering the artery sticks
  • White blood cells (macrophages) ingest apoB particle carrying cholesterol and initiate inflammation
  • VLDL takes lipids (mostly TG, but also cholesterol) out of the liver;
  • VLDL traffic TG to muscle and fat cells and as TG exit the VLDL shrinks, creating IDLs
  • Most IDLs are cleared at the liver but some IDL shrink and become LDLs
  • Liver isn’t as efficient at clearing LDL particles compared to IDLthus extending LDL plasma residence time
  • A normally composed LDL half-life is 2-3 days; compared to VLDL 2-6 hours or IDL 1-2 hours
  • Thus Apo-B test actually measures LDL-P in the blood (vast majority of apoB particles are LDLs)
  • Standard LDL cholesterol test may or may not help
  • LDL cholesterol might be low, but LDL-P could be high: normally the two tests should correlate very well: when they do they are concordant and when they do not they are discordant
  • Particle size has no bearing on whether LDL enters the artery wall or not
  • Insulin resistant Diabetics typically have the small LDL regardless of LDL-C
  • How you can have low LDL-cholesterol and yet high LDL-P numbers (discordance)
  • LDL is supposed to carry primarily cholesterol with little TG (4:1 ratio)
  • Increased LDL/triglyceride level occurs when LDLs are trafficking more TG than normal – in such cases they are therefore carrying less cholesterol than they should. These are therefore cholesterol-depleted LDLs.
  • It takes 40-70% more cholesterol-depleted particles to traffic a given amount of cholesterol
  • In such cases we need a therapy to remove triglycerides from LDL
  • High triglycerides/low HDL-cholesterol ratio (> 3.0) is very indicative “insulin resistance”
  • You can’t guess particle levels by looking at TG or cholesterol values provided in traditional test
  • Triglycerides should be well under 100, even below 70 to be physiologic
  • What if you have large LDL particles and normal Apo B (i.e. normal LDL particle count or LDL-P)
  • Total cholesterol minus HDL is called non-HDL cholesterol: it reveals how much cholesterol is in the apoB particles and thus serves as a better measure of atherogenic apoB particles than does LDL-C
  • However, even Non-HDL cholesterol misses 30% of persons with high apoB (LDL-P) at-risk cases
  • Just get an Apo B and/or LDL particle test and know exactly if atherogenic particles are present
  • It’ll be the best money you’ll ever spend on health
  • You can get Apo B test run in any lab in America
  • Why the NMR Lipoprofile test (LDL-P) is the one to get run (nuclear magnetic resonance spectroscopy)
  • LipoScience is the only lab that runs this test now
  • FDA just approved smaller versions of their analyzer for other labs to purchase
  • Two other technologies exist that measure LDL-P, but those methods are “unproven” in clinical trials
  • Everyone needs to know their LDL particle number (LDL-P or apoB)
  • When you order LDL particle test, they also report standard lipid concentrations
  • Even kids should have a LDL-P test if there is a family history of heart disease, high cholesterol or diabetes or if the kids are obese
  • Severely elevated LDL-P disorder can and should be treated early in life
  • But almost nobody is screening these children at all
  • LDL cholesterol levels under 100 mg/dL has long been the standard
  • LDL-P of 1600 nmol/L is in the 80th percentile
  • A desirable LDL-P of 1000 is the 20th percentile population cut point: 80% of the populations has a higher level
  • LDL-P under 700 is in the 5th percentile population cut point: 5% of folks are less and 95% are higher
  • If particle counts are high, nutritional therapy first and then maybe drugs
  • The most common cause of why LDL-P becomes high: insulin resistance
  • You gotta take carbs out of your die to combat IR or take drugs or both
  • Insulin resistance is at the heart of high LDL-P
  • Why NCEP guidelines don’t say anything about LDL-P: Actually 5 US specialty Society guidelines do advise apoB or LDL-P testing
  • Apo B is in the European guidelines, but not LDL-P (LDL-P by NMR is not available in Europe)
  • Guidelines are never meant to take be cutting edge
  • LDL particle tests are more expensive than regular lipid concentrations
  • LDL-P by NMR in a patient without insurance coverage is four times more costly than traditional tests
  • The majority of doctors don’t know understand or know of Apo B and LDL-P
  • If these tests are done, because so many with fine cholesterol levels will have high apoB, drug use will quadruple and third party payers and govenrment does not want that
  • Drugs are almost always necessary unless you start eating low-carb ASAP
  • The low-fat diet (without carb restriction) is the “worst thing you can do” in a person with IR and high LDL-P
  • The specialty societies (ADA, ACC, AACC, ACE, NLA) are on board with new tests
  • Individual patients often have “discordance” between cholesterol measurements and apoB (LDL-P)
  • I convinced my own doctor to start doing NMR testing
  • Dr. Dayspring’s story about personal lipid revelation:
  • Dr. Jim Otvos inventor of NMR LipoProfile in reality likely saved his life: Dr D had a perfect lipid profile, but a very high LDL-P that never would have been discovered without doing the NMR LipoProfile
  • His 2012 study of diabetics looking at LDL particles (American Journal of Cardiology Sept 2012)
  • Check out information on why LDL particle tests good
  • Once LDL is 190 mg/dl, that’s familial hypercholesterolemia
  • Definitely get an Apo B and LDL-P immediately to see the extent of apoB elevation
  • Normal cholesterol and high LDL-P suggests IR and calls for low-carb diet
  • Some low-carbers have “paradoxical” rise in both LDL particles and LDL-C
  • These people might require aggressive use of drugs
  • The drug therapies that are needed for people with FH
  • Most FH take up to 4 medications to control LDL-P
  • Several new drugs are “in the pipeline” coming soon
  • I’ve personally seen my LDL-cholesterol and LDL-P go way up
  • That shouldn’t happen under normal circumstances
  • These people are “enigmas” with potential yet to be discovered genetic abnormalities
  • This doesn’t mean you should stop your low-carb diet
  • If you’re insulin resistant, you need low-carb
  • My current high-fat, low-carb n=1 experiment
  • Apo B is a worldwide standard for lipid/lipoprotein health
  • If patient is stable, it’s not unreasonable to stop statin and test again (no more than 4 weeks later)
  • Statins (can) have downsides, so take off if possible: in general for folk with high apoB the benefit of statins is vastly superior to any downside)
  • Lipoproteins can change drastically in 2-3 weeks with lifestyle and drugs
  • Retest again after one month to see how it goes off statins
  • Any studies looking at low-carb and decreased LDL-P
  • This is the type of thing modern researchers will be doing
  • There’s support for this, but mainly from Atkins diet studies
  • Lifestyle and/or meds reduce risks of high LDL-P
  • Risk of sterols in the development of arterial plaque
  • Watch Part 1 of Dr. Dayspring’s lecture on sterols
  • Cholesterol, a zoosterol, is one sterol; plants also produce sterols called phytosterols
  • Intestines usually push out plant sterols; not always
  • Some make into lipoproteins and penetrate arteries
  • Measuring phytosterols is probably a good idea: they serve as a biomarker of intestinal sterol absorption
  • Physicians are starting to measure this more and more
  • Cholesterol-absorption blockers can reduce intestinal hyperabsorption of sterols
  • Phytosterols sold in stores may be more harmful than good if taken by a person who is a hyperabsorber
  • Humans with normal sterol absorption would not be harmed by phytosterols
  • A hyperabsorber taking phytosterols might lower LDL cholesterol, but raise phytosterols
  • Without assaying sterol absorption These products may not be “heart-healthy” at all, just “hocus pocus”
  • The phytostanol, sitostanol, (Benecol) reduce cholesterol absorption and stanols are not absorbed, so this canbe an excellent functional food that safely lowers LDL-C and LDL-P
  • LDL cholesterol levels may or may not be associated with LDL particle concentrations
  • 20 years ago, in assaying LDL we’d were “extolling” LDL-cholesterol tests
  • Changing things in medicine is a slow, hard road
  • Patients must educate yourself and get what you need done
  • Don’t assume doctors are “genius” on all health matters, especially cardiovascular biomarkers
  • How the various cholesterol numbers are calculated
  • Calculated LDL-cholesterol is an imprecise equation
  • If your trigs are under 100, divide by 5 for VLDL-cholesterol determination: Once you have VLDL-C, you can calculate LDL-C using the equation LDL-C = TC minus HDL-C – VLDL-C
  • Triglycerides is a key marker that few health care professionals truly, understand
  • Trigs over 70 in an IR adult, LDL-P needs checking
  • Large VLDL’s and high total and small LDL-P are markers of insulin resistance
  • Kids need to “get off the damn carbs” and substitute fat and protein instead
  • Whether it’s possible to have “too low” cholesterol
  • You don’t need cholesterol in blood, but in the cells and all cells in the body manufacture it
  • a href=http://en.wikipedia.org/wiki/Hypobetalipoproteinemia>Hypobetalipoproteinemia have low LDL-P (apoB) and very low cholesterol levels
  • These people tend to live a very long life and suffer no cholesterol deficiency issues
  • What Apo E genotype issues you should be aware of
  • Apo E4 is a marker of elevated risk of heart disease”
  • ApoE2 is usually desirable but Apo E2 with high triglycerides is a high risk lipoprotein abnormality with normal LDL-P: they have too many VLDLs and IDLKs, but not LDLs.
  • Apo E4 is also associated with Alzheimer’s disease
  • A ketogenic diet might ward off Alzheimer’s longer
  • “Drown yourself in omega-3 fatty acids” if Apo E4
  • ApoE genotyping just a one-time genetic test you run
  • Whether an Apo E4 needs to lower their fat intake is truly not known at present
  • Are they REALLY over-absorbing fat–maybe, maybe not
  • If your lifestyle controls Apo B, no need to worry
  • What one test gives most info on heart disease risk: ApoB and LDL-P
  • No matter what Apo B is, other tests such as inflammatory markers can also tell about CV risk
  • The totality of tests help doctors treat you better
  • Triglycerides and Apo B/LDL-P gets most info needed to start
  • Christine had 300 trigs, dropped to 130 in 6 weeks
  • Can’t change LDL-P by eating carbs day before test (LDL half life is typically 3 days)
  • Takes trigs a few days to alter lipoprotein metabolism and jack up your LDL-P
  • If Apo B and LDL-P come back one high, one normal – discordance is present
  • It happens in 10-12% of people; repeat test again
  • If LDL-P is high and Apo B is normal, there is no consensus on what to do
  • LDL-P tends to “outperform” Apo B as a key marker
  • Why HDL cholesterol decreases on autoimmune issues
  • Endothelial lipase expressed with such diseases increases HDL catabolism
  • Women with anorexia tend to have transient high cholesterol as adipocytes are a cholesterol storage tissue
  • Wait one month after weight loss and then test again with high LDL-C and LDL-P
  • Thus weight loss can make transiently make your LDL cholesterol seem higher
  • What he thinks about having a heart scan conducted
  • His concern over having a CT scan of your chest: too much radiation
  • Why do I care about this if LDL-P and Apo B is high: the image result would not change therapy
  • Whether LDL-P and Apo B are impacted by non-fasted: NO
  • LDL particles are present in plasma on average 3 days and are is a steady state and thus levels are stable over several days
  • Liposcience does not offer apoB testing: they provide LDL-P by NMR. If you have LDL-P you do not need apoB
  • The VAP test offers a calculated Apo B–BOGUS!
  • You have to insist on a MEASURED Apo B test (using a protein immuno assay)
  • Chris Masterjohn says major deviations in cholesterol
  • You’re “playing with fire” with traditional testing
  • It’s time to say goodbye to these kinds of tests
  • You gotta move on when newer biomarkers come along
  • We must abandon traditional cholesterol testing
  • Get the new tests in there as the standard bearer
  • It’s a “total joke” when heart disease is #1 killer
  • Doctors often think someone advocating particle testing is “some quack”
  • Never be afraid to change doctors if necessary
  • Publisher asked me to write layman’s cholesterol book
  • Peter Attia’s “Straight Dope On Cholesterol” series
  • Your doctor better know Apo B and LDL-P or fire him
  • Dr. Dayspring on Twitter: @DrLipid


  • Dr. Dayspring on Twitter: @DrLipid
     
    TRY THIS NEW LOW-CARB SNACK OPTION FROM NICK’S STICKS:

    NOTICE OF DISCLOSURE: http://cmp.ly/3
    There are five ways you can listen to Episode 29:
    1. LISTEN LIVE ON THURSDAY NIGHTS AT 7PM ET by calling (712) 432-0900 or on Skype at “freeconferencing.7124320900″–whether you call or Skype, be sure to use the access code “848908.” You can listen and even participate on the topic discussion by asking your questions directly to the featured expert.
    2. Listen at the iTunes page for the podcast:

    3. Listen and comment about the show at the official web site for the podcast:

    4. Download the MP3 file of Episode 29 [109:15m]:

    5. Listen on the Stitcher app–NO DOWNLOADING!
  • Monday, 8 April 2013

    Low-Carb Cholesterol Concerns Unnecessary


    Low-Carb Cholesterol Concerns Unnecessary

    Monday, February 13, 2006

    Dr. Volek says total cholesterol not as important as triglyceride/HDL ratio

    "As people in favor of the low-carb diet will jump on these results, I really try to say that this is limited evidence," Dr. Alain J. Nordmann warned regarding his new study.

    Hoo boy, can you tell this one's gonna be a doozy?!

    This MedPage Today article is about a new study that shows nearly identical weight loss for people on low-fat and low-carb diets, but there is concern about the low-carb group elevating their LDL cholesterol levels.

    Researchers led by Dr. Nordmann from University Hospital in Basel, Switzerland conducted five controlled clinical trials on nearly 450 overweight study participants over a one-year time period, with half of them placed on a low-fat diet and the other half were on a low-carb diet.

    Dr. Nordmann found that the low-carb diet group had lost more weight than the low-fat diet group after six months, but the weight loss was almost even after one year. Blood pressure was also nearly identical, the researchers noted.

    However, they discovered that there was an increase in the total cholesterol and low-density lipoprotein (LDL "bad") cholesterol for the group following a low-carb diet. They added that the rise in LDL cholesterol for the low-carb diet group completely negated any increase in HDL "good" cholesterol and decreases in triglyceride levels.

    This study was published in the Archives of Internal Medicine on Monday.

    Okay, so the low-carb diet performed JUST AS WELL as the low-fat diet in the study. Is this not GREAT news?! We've been told that low-carb is not as effective because all you lose is "water weight," but clearly that is not the case. The low-fat recommendation can no longer be held in high esteem for bringing about the most weight loss anymore.

    Do you think doctors are gonna start recommending low-carb living all of a sudden, though? Not likely. Here's why. They're still worried about the supposed negative effect it has on cholesterol levels. We'll get into that in a moment.

    For the purposes of this study, "low-carb" was defined as 60g of carbohydrates per day while "low-fat" was 30% of energy intake as fat.

    I'm sure both sides will balk at these levels of carbs and fat respectively.

    Most genuinely "low-carb" diets start off at 20g of carbohydrates and rise to varying rates between 20-60g daily during weight loss. It all depends on the individual and subjecting some people to as many as 60g carbs per day may not have been the ideal way to help them maximize their weight reduction. In other words, some of those in the "low-carb" group COULD have lost more weight if they were allowed to decrease their carb intake to a level where they would still lose weight.

    And, to be fair, most people who follow a "low-fat" diet as recommended by low-fat guru Dr. Dean Ornish try to keep their fat intake down to about 20-25% of their total caloric intake. Eating more fat than that, as we have seen from low-fat supporters in the past few days, is not considered "low-fat" to them.

    Nevertheless, the study results are intriguing even if the conclusions are just a little bit off.

    You see, this business about low-carb diets causing total cholesterol and LDL cholesterol to go up is frankly irrelevant in the face of the remarkable increases seen in HDL cholesterol and drops in triglycerides on a low-carb diet.

    After six months, the researchers found the low-carb diet participants saw their HDLs go up an average of 4.6 mg/dL and their triglycerides go down 22.1 mg/dL, with slight increases in LDL cholesterol. On the flip side, the low-fat diets saw their LDL cholesterol fall an average of 5.4 mg/dL and the total cholesterol drop an average of 10.1 mg/dL.

    So which is better? How about if we ask University of Connecticut, Storrs assistant professor Dr. Jeff Volek for the answer to that question.

    I met Dr. Volek during the Nutritional & Metabolic Aspects of Carbohydrate Restriction conference in Brooklyn, NY in January. He presented the findings of a recent research study of his own regarding the effect of a very high-fat, low-carb diet on cholesterol compared with a standard low-fat diet.

    In his 12-week study, Dr. Volek used study participants who had moderately high triglycerides (over 150) and relatively normal HDL levels (below 50). Half of the participants were placed on a low-fat diet consisting of less than 30 percent of total caloric intake from fat (as is the standard with the American Heart Association) and the other half consumed a low-carb diet with an extraordinarily-high 85 percent fat intake to test the fat tolerance of the study participants.

    What were the results of this study after just three months?

    The low-carb diet group lost TWICE as much weight as the low-fat diet group while total cholesterol and LDL cholesterol levels decreased equally among both groups.

    But the most compelling and exciting results of this study is what happened to the HDL and triglycerides. The HDL rose by 8 percent in the male participants and 17 percent in the female participants in the low-carb diet group. The low-fat diet group, on the other hand, actually saw their HDL "good" cholesterol numbers FALL by 1 percent!

    As for the triglyceride numbers, the low-carb diet group decreased their triglycerides by a whopping 51 percent compared with a mere 15 percent drop by the low-fat diet group. This was a SIGNIFICANT difference between the two groups in the study.

    Dr. Volek pointed out that the reason this study is noteworthy is because it underlines the importance of how a low-carb diet makes the triglyceride/HDL ratio so much better than a low-fat diet. He said this ratio is the real key when looking at cholesterol numbers.

    For far too long, doctors have exclaimed how important it is to keep your total cholesterol number below 200, right? Isn't that what all the hoopla over statin drugs is about? "Aim lower," one of the obnoxious ads for cholesterol-lowering medicine blares out to us on our television sets, but why? If your triglyceride/HDL ratio is incredible, then you don't need to worry about how high your total cholesterol is. You just don't.

    My most recent blood work revealed that my triglycerides are 57 and my HDL is 71. That makes my triglyceride/HDL ratio a miniscule 0.83. My doctor has even said with a ratio that good (it was A LOT BETTER than his!), I don't need to worry that my total cholesterol being 201.

    And that's the message of the study conducted by Dr. Volek, too. Just like on the issue of fat, Americans have been scared half to death about the supposed dangers of what they perceive as high cholesterol numbers. But they've been duped yet again! We need to learn from the work of people like Dr. Volek and realize there are much more important numbers to look at (trigylcerides and HDL cholesterol) than the total cholesterol and LDL cholesterol.

    Unfortunately, this fact has been completely overlooked by Dr. Nordemann.

    "Because no trials have yet examined the risk of heart attack or death in people on low-carbohydrate diets, it's unclear whether the beneficial effects that low-carbohydrate diets appear to have on HDL and triglyceride levels cancel out their apparent negative effects on overall and LDL cholesterol levels," Dr. Nordmann said.

    Why is that, Dr. Nordemann? Why are the positive effects on HDL and triglyceride levels negated? You can't just overlook these improvements and write them off as irrelevant for the low-carb dieters! The results of your study may not be what you want them to be, but they are what they are.

    As for weight loss, Dr. Nordemann said the "not clinically relevant" differences in weight reduction make it impossible for him to recommend a low-fat diet over the long-term.

    "We believe there is still insufficient evidence to make recommendations for or against the use of low-carbohydrate diets to induce weight loss, especially for durations longer than six months," he exclaimed. "Such diets currently cannot be recommended for prevention of cardiovascular disease."

    Well, we'll see about that won't we, Dr. Nordemann?! I've been livin' la vida low-carb for over two years (AND I'VE LIVED TO TELL ABOUT IT, TOO!) with nothing but positive news to share about my weight and health. This garbage science from people like Dr. Nordemann just makes me want to hurl. Thank God for brave and bold researchers like Dr. Volek who are so willing to just share the facts about how a low-carb diet is making a real difference in the lives of the people who do them.

    You can e-mail Dr. Alain J. Nordmann about his study at dok20052@healthindex.ch as well as Dr. Jeff Volek about his study at jeff.volek@uconn.edu.